LAG3 and arthritic joint disease: In our study, we also proved that Fgl1, the new-found major ligand of LAG-3 (15), can significantly decrease inflammatory cytokine level in local paw tissue (Figure 5), prevent joint inflammation, cellular infiltration and bone deformation and attenuate arthritis progression in a CIA mouse model (Figure 3D).